David Barad, MD, works for the Center for Human Reproduction in New York, NY. The Center, one of the oldest facilities in the country to specialize in IVF, deals with a number of reproductive challenges facing couples today. Several of the treatments offered include in-vitro fertilization, frozen egg donor programs (the Center has one of the largest in the world), and gender selection. Today, Dr. Barad is an Associate Clinical Professor of Epidemiology, Social Medicine, and OBGYN at Albert Einstein College of Medicine in the Bronx, NY. He is also currently involved in clinical research on the health of post-menopausal women.
Education and Training
Rutgers Medical School
American Board of Obstetrics and Gynecology (Obstetrics and Gynecology)
Obstetrics and GynecologyAmerican Board of Obstetrics and GynecologyABOG- Reproductive Endocrinology/Infertility
Dr. David Barad M.D.'s Expert Contributions
I will presume that you are asking if it is safe for a pregnant woman to receive oral sex. The answer is that any sexual activity is generally safe. The exception to this rule is that there is some risk of serious problems if air is blown into the vagina, especially when you are pregnant. So, if your partner can refrain from blowing bubbles, you should be OK. READ MORE
Is the discharge white and curdy like cottage cheese, or is it like white mucous? The first could be a yeast infection while the second may just be a normal response to high estrogen, especially if you recently began taking a new medication. Neither case is very serious, but if you want to sort this out, possibly begin treatment, you should see your doctor. READ MORE
IUDs are among the safest and most effective forms of contraception. An IUD can usually be inserted without problems no matter how many you have had. In the past, some IUDs needed to be exchanged for a new one every year. Many doctors are not comfortable inserting an IUD. If not done properly, there can be complications, though an experienced doctor should have no problem. If your past IUD was removed because of an infection or other problem, then your doctor my not want to expose you to the risk of that problem happening again. If you really want to know what your doctor was thinking, you should ask her. READ MORE
An enlarged, asymptomatic uterus is not really a problem. The most common cause of uterine enlargement is pregnancy, but you have probably already ruled that out. The next most common cause would be a fibroid. Fibroids are very common affection about 40% of all women over 40 years old. In most cases, they will be without symptoms and could be left alone. If you have symptoms, the recommended treatment will depend on your age and location. READ MORE
Fibroids almost always grow back, but may not grow in the same place and so may not cause symptoms. Fibroids are so common that a finding of an asymptotic fibroid on an annual exam should not lead to an automatic recommendation for surgery. READ MORE
A correctly performed abortion will not decrease the chance of future pregnancy. However, the chance of pregnancy even without an abortion dramatically will decrease after the age of 36, so if you are older you should weigh your choice carefully. READ MORE
Hormonal is the correct answer. The most common cause of new onset breast tenderness is due to the hormonal changes of pregnancy. READ MORE
Masturbatiion is a healthy way of relieving sexual tension when your partner is away. It does not cause incontinence. Some women do lose a small amount of urine during orgasm but this is only a problem if it bothers you and can be avoided by emptying your bladder before beginning. Incontinence associated with coughing or sneezing is most often due to pelvic changes that occur sometimes years after childbirth. READ MORE
No this does not mean you have an infection. Menstrual fluid does change color on a sanitary napkin and, over the course of several hours may appear to be green along the edges. Of course, if you have other symptoms of vaginitis, such as itching or if you are experiencing pelvic pain, you should be seen by a health professional who could evaluate you fully. READ MORE
Implantation bleeding is supposed to occur about 5 to 6 days after ovulation around the time of implantation. However, here is no scientific evidence that any bleeding occurs at the time of implantation, even though this is commonly stated as being true in many internet sites. While some bleeding in the second half of the cycle may be common, it is not a sign of pregnancy. More likely it is just a result of further fluctuation in hormonal levels. So the "mistake" is actually the other way around, mistaking early menstrual bleeding as a sign of pregnancy, when it is not.. READ MORE
About 25% of women who have had chemotherapy for breast cancer will have resumption of menses. The factors that favor resumption of menses are youth, normal BMI, the type of chemotherapy used and whether or not they use hormonal medication like Tamoxifen following treatment. Even so, resumption of menses is not the same as fertility. Even if menses has returned, there is a greater chance of early menopause. Women in this situation need to speak with their doctors and try to balance their reproductive goals with the need to give themselves the best chance of survival. Some women are able to freeze eggs or ovarian tissue before starting chemotherapy. Some will try to freeze eggs or embryos before starting long term endocrine treatment. In any case, it is an uphill battle with many difficult decisions. READ MORE
I'm not sure what your doctor meant by a T-score in this case. A T-Score is a statistical test that is used to see if a event or lab test was likely to have occurred by chance. It may be that your doctor's lab reports significance based on T-scores. In any case, the bottom line is that if you feel pregnant and you are "late" with your period you should definitely repeat the test. READ MORE
Spina Bifida is a congenital problem associated with mechanical and anatomic issues that can make sexual function difficult. Some men can have erections, but will have difficulty ejaculating. However, there is no evidence that Spina Bifida affects the ability to produce sperm. Most couples with a partner with Spina Bifida will be able to be parents, some may need help if there are mechanical problems having sexual intercourse. READ MORE
Every woman experiences different symptoms. Back pain before your periods might be due to endometriosis. Other symptoms of endometriosis might be painful intercourse or pain with bowel movements. You should probably see a doctor to have this evaluated, in the meantime, it should be safe to use pain medications like Advil. READ MORE
A home pregnancy test could definitely show an incorrect reading. If you feel pregnant, you should see your doctor to confirm what is going on. READ MORE
Few things are as effective or simple to use as oral contraceptives and the safety profile of OCs is really very good. When used properly, OCs have a 99% effectiveness, much better than condoms. However, there are other methods that are also quite good. IUDs are available. Modern IUDs can be left in place for many years and provide continuous contraception without having to remember to refill a prescription or to take a pill. Some IUDs have hormones embedded in them, others have copper wire that provides some added measure of protection. All are somewhat costly, but given the years of protection are cheaper on a per year basis. On the other end of the spectrum, you could be fitted for a diaphragm which together with spermicidal jelly provides fairly effective relief for a married couple. You should speak with your doctor who can give you more information. READ MORE
Emergency contraception has two main actions, first it may prevent ovulation to avoid becoming pregnant, second it may prevent implantation. These activities should be effective if it is used within the designated time period of 72 hours. No intervention can promise 100% effectiveness. If you find you are late with your menstrual period, you should definitely be concerned. READ MORE
- Incidence of bowel injury due to dense adhesions at the sight of direct trocar insertion.
- Habitual tea consumption and risk of osteoporosis: a prospective study in the women's health initiative observational cohort.
- The Women's Health Initiative postmenopausal hormone trials: overview and baseline characteristics of participants.
- Retinoblastoma in a child conceived by in vitro fertilisation.
- Fracture risk among breast cancer survivors: results from the Women's Health Initiative Observational Study.
- Use of follicle-stimulating hormone test to predict poor response in in vitro fertilization.
- Osteoporosis and rate of bone loss among postmenopausal survivors of breast cancer.
- Increased oocyte production after treatment with dehydroepiandrosterone.
- Effects of transdermal testosterone application on the ovarian response to FSH in poor responders undergoing assisted reproduction technique-a prospective, randomized, double-blind study.
- Gender as risk factor for autoimmune diseases.
- Age-specific levels for basal follicle-stimulating hormone assessment of ovarian function.
- Mild versus standard in-vitro fertilisation techniques.
- The choice of gender: is elective gender selection, indeed, sexist?
- Infertility surgery by laparotomy.
- A pilot study of premature ovarian senescence: I. Correlation of triple CGG repeats on the FMR1 gene to ovarian reserve parameters FSH and anti-Müllerian hormone.
- A pilot study of premature ovarian senescence: II. Different genotype and phenotype for genetic and autoimmune etiologies.
- Correlation of antimüllerian hormone and baseline follicle-stimulating hormone levels.
- Androgen priming before ovarian stimulation for IVF.
- Can the FMR1 (fragile X) gene serve as predictor of response to ovarian stimulation?
- Is the immunological noise of abnormal autoimmunity an independent risk factor for premature ovarian aging?
- Comparing anti-Müllerian hormone (AMH) and follicle-stimulating hormone (FSH) as predictors of ovarian function.
- Less may, indeed, be less: multicollinearity in studies of ovarian reserve.
- Dehydroepiandrosterone treatment of ovarian failure.
- Patients are entitled to maximal IVF pregnancy rates.
- Severity of prematurity risk in spontaneous and in vitro fertilization twins: does conception mode serve as a risk factor?
- Correlation of triple repeats on the FMR1 (fragile X) gene to ovarian reserve: a new infertility test?
- Miscarriage rates after dehydroepiandrosterone (DHEA) supplementation in women with diminished ovarian reserve: a case control study.
- Can prematurity risk in twin pregnancies after in vitro fertilization be predicted? A retrospective study.
- Relative effects of tamoxifen, raloxifene, and conjugated equine estrogens on cognition.
- Effects of race/ethnicity on triple CGG counts in the FMR1 gene in infertile women and egg donors.
- Can the FMR1 gene predict early ovarian aging?
- Ovarian reserve determinations suggest new function of FMR1 (fragile X gene) in regulating ovarian ageing.
- The impact of fetal gender on prematurity in dichorionic twin gestations after in
- Anti-Mullerian hormone (AMH) defines, independent of age, low versus good
- Discordances between follicle stimulating hormone (FSH) and anti-Müllerian hormone (AMH) in female infertility.
- Can egg donor selection be improved?--A pilot study.
- Improvement in diminished ovarian reserve after dehydroepiandrosterone supplementation.
- Ultrarapid freezing (URF) of mouse and human preembryos: a modified approach.
- Misplaced obsession with prospectively randomized studies.
- The FMR1 gene as regulator of ovarian recruitment and ovarian reserve.
- Dehydroepiandrosterone (DHEA) reduces embryo aneuploidy: direct evidence from preimplantation genetic screening (PGS).
- FMR1 genotype with autoimmunity-associated polycystic ovary-like phenotype and decreased pregnancy chance.
- Do chromosomally abnormal pregnancies really preclude autoimmune etiologies of spontaneous miscarriages?
- Utility of age-specific serum anti-Müllerian hormone concentrations.
- Defining ovarian reserve to better understand ovarian aging.
- Successful treatment of unresponsive thin endometrium.
- Association of FMR1 genotypes with in vitro fertilization (IVF) outcomes based on ethnicity/race.
- Live birth chances in women with extremely low-serum anti-Mullerian hormone levels.
- Gestational dermatosis shortly after implantation associated with parental class II HLA compatibility and maternal immune activation: preliminary report of a prospective case series.
- Dehydroepiandrosterone (DHEA) supplementation in diminished ovarian reserve (DOR).
- Cutting edge assessment of the impact of autoimmunity on female reproductive success.
- Low-intensity IVF: real progress?
- The role of androgens in follicle maturation and ovulation induction: friend or foe of infertility treatment?
- Updated screening protocol for abortion services.
- Patterns and predictors of sexual activity among women in the Hormone Therapy trials of the Women's Health Initiative.
- Toward a better understanding of functional ovarian reserve: AMH (AMHo) and FSH (FSHo) hormone ratios per retrieved oocyte.
- A case-control pilot study of low-intensity IVF in good-prognosis patients.
- Comparison of ovarian FMR1 genotypes and sub-genotypes in oocyte donors and infertile women.
- The impact in older women of ovarian FMR1 genotypes and sub-genotypes on ovarian reserve.
- Follicle stimulating hormone and anti-Müllerian hormone per oocyte in predicting in vitro fertilization pregnancy in high responders: a cohort study.
- Intermediate and normal sized CGG repeat on the FMR1 gene does not negatively affect donor ovarian response.
- Hype or hope? Ethical and practical considerations with clinical research in women with diminished ovarian reserve.
- Lessons from elective in vitro fertilization (IVF) in, principally, non-infertile women.
- The impact of androgen metabolism and FMR1 genotypes on pregnancy potential in women with dehydroepiandrosterone (DHEA) supplementation.
- Differences in ovarian aging patterns between races are associated with ovarian
- BRCA1/2 mutations appear embryo-lethal unless rescued by low (CGG n<26) FMR1 sub-genotypes: explanation for the "BRCA paradox"?
- A review of, and commentary on, the ongoing second clinical introduction of preimplantation genetic screening (PGS) to routine IVF practice.
- A pilot cohort study of granulocyte colony-stimulating factor in the treatment of unresponsive thin endometrium resistant to standard therapies.
- Starting and resulting testosterone levels after androgen supplementation determine at all ages in vitro fertilization (IVF) pregnancy rates in women with diminished ovarian reserve (DOR).
- Hypoandrogenism in association with diminished functional ovarian reserve.
- A pilot trial of large versus small diameter needles for oocyte retrieval.
- Clinical relevance of combined FSH and AMH observations in infertile women.
- Does hormonal contraception prior to in vitro fertilization (IVF) negatively affect oocyte yields? A pilot study.
- The status of public reporting of clinical outcomes in assisted reproductive technology.
- Is androgen production in association with immune system activation potential evidence for existence of a functional adrenal/ovarian autoimmune system in women?
- Age at menarche: a predictor of diminished ovarian function?
- Association of abnormal ovarian reserve parameters with a higher incidence of aneuploid blastocysts.
- Reply of the authors.
- Reply of the authors.
- Defining assisted reproductive technology success.
- Therapeutic interventions into early stages of follicle maturation: a new treatment paradigm after over 50 years of modern infertility therapy.
- Do BRCA1/2 mutations and low FMR1 alleles interact or not?
- Preimplantation genetic screening is alive and very well: really?
- Endocrine autoimmune diseases and female infertility.
- What 'misguided campaign' against single embryo transfer?
- The danger of ignoring pregnancy and delivery rates in ART.
- Immunoreactive substance P in the human ovary.
- Preimplantation genetic screening (PGS) still in search of a clinical application: a systematic review.
- The "graying" of infertility services: an impending revolution nobody is ready for.
- Utilizing FMR1 gene mutations as predictors of treatment success in human in vitro fertilization.
- Absence of BRCA/FMR1 correlations in women with ovarian cancers.
- How the FMR1 gene became relevant to female fertility and reproductive medicine.
- Ovarian reserve screening before contraception?
- Establishment of comparative performance criteria for IVF centers: correlation of live birth rates in autologous and donor oocyte IVF cycles.
- Is it time for a paradigm shift in understanding embryo selection?
- Advanced reproductive age and maternal mortality.
- Some aspects of interactivity between endocrine and immune systems required for successful reproduction.
- Prospectively assessing risk for premature ovarian senescence in young females: a new paradigm.
- Intracytoplasmic sperm injection and reproductive outcomes.
- Genetics of androgen metabolism in women with infertility and hypoandrogenism.
- The impact of thyroid function and thyroid autoimmunity on embryo quality in women with low functional ovarian reserve: a case-control study.
- Relative importance of AMH and androgens changes with aging among non-obese women with polycystic ovary syndrome.
- Outcomes of Fresh and Cryopreserved Oocyte Donation.
- Why Prospectively Randomized Clinical Trials Have Been Rare in Reproductive Medicine and Will Remain So?
- Randomized controlled trial of minimal stimulation versus conventional in vitro fertilization.
- Fresh vs Cryopreserved Donor Oocytes--Reply.
- Associations between peripheral androgens and cortisol in infertile women.
- The impact of patient preselection on reported IVF outcomes.
- Systemic Inflammation and Autoimmunity in Women with Chronic Endometritis.
- Effectiveness of in vitro fertilization with preimplantation genetic screening: a reanalysis of United States assisted reproductive technology data 2011-2012.
- The importance of adrenal hypoandrogenism in infertile women with low functional ovarian reserve: a case study of associated adrenal insufficiency.
- Risks of spontaneously and IVF-conceived singleton and twin pregnancies differ, requiring reassessment of statistical premises favoring elective single embryo transfer (eSET).
- Improvements in IVF in women of advanced age.
- Effect of Embryo Banking on U.S. National Assisted Reproductive Technology Live Birth Rates.
- Definition by FSH, AMH and embryo numbers of good-, intermediate- and poor-prognosis patients suggests previously unknown IVF outcome-determining factor associated with AMH.
- How FSH and AMH reflect probabilities of oocyte numbers in poor prognosis patients with small oocyte yields.
- In reference to 'Strategies to manage refractory endometrium: state of the art 2016'.
- Accuracy of preimplantation genetic screening (PGS) is compromised by degree of mosaicism of human embryos.
- Utilization of third-party in vitro fertilization in the United States.
- New PCOS-like phenotype in older infertile women of likely autoimmune adrenal etiology with high AMH but low androgens.
- Systematic review of worldwide trends in assisted reproductive technology 2004-2013.
- Redirecting reproductive immunology research toward pregnancy as a period of temporary immune tolerance.
- Age-Specific IVF Outcomes in Infertile Women With Baseline FSH Levels ≥20 mIU/mL.
- Elective single-embryo transfer (eSET) reduces pregnancy rates and should only be used in exceptional circumstances: FOR: The statistically flawed model of eSET.
- Response to comment on: Gleicher N et al., 2016. Reprod biol endocrinol Sep 5;14(1):54.
- A single trophectoderm biopsy at blastocyst stage is mathematically unable to determine embryo ploidy accurately enough for clinical use.
- CDC-reported assisted reproductive technology live-birth rates may mislead the public.
- Potential therapeutic applications of human anti-Müllerian hormone (AMH) analogues in reproductive medicine.
- First birth following spindle transfer.
- Letter to the Editor: Including the Zona Reticularis in the Definition of Hypoadrenalism and Hyperadrenalism.
- Gamete intrafallopian tube transfer (GIFT): making laparoscopy more than "diagnostic".
- The in vitro fertilization program at Albert Einstein College of Medicine, Bronx, New York.
- Effects of smoking on the levels of antioxidant beta carotene, alpha tocopherol and retinol in human ovarian follicular fluid.
- An updated protocol for abortion surveillance with ultrasound and immediate pathology.
- Management of endometriosis in women older than 40 years of age.
- Semen analyses in 1,283 men from the United States over a 25-year period: no decline in quality.
- Abnormal sperm morphology is highly predictive of pregnancy outcome during controlled ovarian hyperstimulation and intrauterine insemination.
- Direct laparoscopic entry using a sharp and dull trocar technique.
Areas of expertise and specialization
Faculty Titles & Positions
- Worldwide Public Speaking -
- Investigator at the New York Clinical Center of the Women’s Health Initiative -
- Director of Assisted Reproductive Tecnology Center for Human Reproduction 2003 - 2017
- American Society for Reproductive Medicine
- American Congress of Obstetricians and Gynecologists
- New York Obstetrical Society
- Colum P&S
- Sloane Hospital for Women of Columbia Presbyterian Medical Center
- Sloane Hospital for Women/ Columbia Presbyterian Medical Center (Obstetrics and Gynecology)
Faculty Titles & Positions
- Colum P&S
- Sloane Hospital for Women of Columbia Presbyterian Medical Center
- Sloane Hospital for Women/ Columbia Presbyterian Medical Center (Obstetrics and Gynecology)
- Brigham and Women's Hospital (Reproductive Endocrinology)
Professional Society Memberships
- New York State Medical Society, American Society for Reproductive Medicine, American College of Obstetricians and Gynecologists, American Medical Association
Articles and Publications
What do you attribute your success to?
Engages in Creative Research and Utilizes This to Help his Patients
Favorite professional publications
- New England Journal of Medicine
- Mount Sinai Roosevelt ( New York, NY )
- Aetna Advantage Dental
- Aetna Affordable Health Choices limited benefits insurance plan
- Aetna Choice POS
- Aetna Choice POS (Aetna HealthFund)
- Aetna Choice POS II
- Aetna Choice POS II (Aetna HealthFund)
- Aetna Dental PPO/PDN
- Aetna Golden Choice Plan (PPO)
- Aetna Golden Medicare Plan (HMO)
- Aetna Health Network Only
- Aetna Health Network Option
- Aetna HealthFund Aetna Choice POS
- Aetna HealthFund Aetna Health Network Only
- Aetna HealthFund Aetna Health Network Option
- Aetna HealthFund HMO
- Aetna HealthFund Open Access Aetna Select
- Aetna HealthFund Open Access Elect Choice EPO
- Aetna HealthFund Open Access Managed Choice POS
- Aetna HealthFund Open Access POS II
- Aetna HealthFund Open Choice PPO
- Aetna Medicare Open (Private Fee-for-Service)
- Aetna Medicare Plan (HMO/Open Access HMO)
- Aetna Medicare Plan (PPO)
- Aetna Medicare Select (HMO)
- Aetna Medicare Special Needs
- Aetna Open Access Elect Choice (EPO)
- Aetna Open Access HMO
- Aetna Open Access Managed Choice (POS)
- Aetna Select
- Aetna Value Network HMO
- Aetna Vision
- Aetna Whole Health - Banner Health OAMC
- Aetna Whole Health - MW Comm. Health Solutions
- Aetna Whole Health- Banner Health Network HMO
- Aetna Workers' Comp Access
- Aexcel Aetna Select
- Aexcel Aetna Select (Open Access)
- Aexcel Choice POS II
- Aexcel Choice POS II (Aetna HealthFund)
- Aexcel Elect Choice EPO
- Aexcel Elect Choice EPO (Open Access)
- Aexcel Managed Choice POS
- Aexcel Managed Choice POS (Open Access)
- Aexcel Open Access Aetna Select (Aetna HealthFund)
- Aexcel Open Access Elect Choice (Aetna HealthFund)
- Aexcel Open Access Managed Choice POS (HealthFund)
- Aexcel PPO
- Aexcel PPO (Aetna HealthFund)
- Aexcel Plus
- Aexcel Plus Aetna Select
- Aexcel Plus Aetna Select (Open Access)
- Aexcel Plus Choice POS II
- Aexcel Plus Choice POS II (Aetna HealthFund)
- Aexcel Plus Elect Choice EPO
- Aexcel Plus Elect Choice EPO (Open Access)
- Aexcel Plus Managed Choice POS
- Aexcel Plus Managed Choice POS (Open Access)
- Aexcel Plus Open Access Aetna Select (Aetna HealthFund)
- Aexcel Plus Open Access Elect Choice (Aetna HealthFund)
- Aexcel Plus Open Access Managed Choice POS (HealthFund)
- Aexcel Plus PPO
- Aexcel Plus PPO (Aetna HealthFund)
- Affordable Health Choices
- Behavioral Healthcare Program
- Better Health
- Better Health Kids Pennsylvania
- Elect Choice (EPO)
- Employee Assistance Program
- HCA Smart Care Base (PPO)
- HCA Smart Care Plus (PPO)
- HCA Smart Care Select
- HCA Smart Care Value (PPO)
- HCA Well Care (Level 3)
- HCA Well Care (Levels 1 & 2)
- HMO (Open Access)
- HMO Deductible Plan
- HMO Deductible Plan (CA members only)
- Healthy New York HMO
- Illinois Community Network
- Illinois Managed Choice Network
- LM Healthworks
- MCOA 7500
- Managed Choice (POS)
- Managed Choice Open Access
- Managed Choice Open Access HDHP
- Managed Choice Open Access Value 1500
- Managed Choice Open Access Value 5000
- Medicare Plan (HMO / Open Access HMO)
- Medicare Plan (PPO)
- Medicare Rx Premier (PDP)
- NYC Community Plan
- National Advantage Program
- New York Certified PPO (Workers' Comp)
- New York Recommendation of Care PPO (Workers' Comp)
- North Shore LIJ Employee Health Plan (CIIPA)
- Open Access Aetna Select
- Open Choice (PPO)
- PCP Referral Plan (TX only)
- Preventative and Hospital Care 3000
- Quality Point-of-Service (QPOS)
- Savings Plus of Arizona
- Savings Plus of Chicago, IL
- Savings Plus of Florida (Brevard and Tampa)
- Savings Plus of Lake County, OH
- Savings Plus of Oklahoma
- Savings Plus of Texas
- Signature Administrators
- Student Health Plans
- Texas CHIP
- Texas STAR (Medicaid)
- Texas Voluntary/Informal (Workers' Comp)
- Traditional Choice Indemnity
- Vitalidad Mexico con Aetna
- Vitalidad Plus California con Aetna
- Volunteer Plan
- Blue Cross Blue Shield (BCBS)
- Alliance Value and Core Plans
- City of New York Employees
- DC37 MED-TEAM
- EmblemHealth CompreHealth
- EmblemHealth CompreHealth EPO
- EmblemHealth Consumer Direct EPO
- EmblemHealth Consumer Direct PPO
- EmblemHealth EPO
- EmblemHealth InBalance EPO
- EmblemHealth InBalance PPO
- EmblemHealth PPO
- EmblemHealth PPO/EPO (GHI)
- Federal Employees FEDVIP
- Federal Employees FEHB
- GHI HMO
- GHI Healthy NY HDHP (EPO)
- GHI PPO/EPO
- GHI Small Business Advantage Plan
- New York City Transit
- New York City Transit Retirees
- VIP (Medicare Advantage HMO)
- VIP Essential (Medicare Advantage HMO)
- VIP High Option (Medicare Advantage HMO)
- AARP MedicareComplete
- AARP MedicareComplete SecureHorizons
- AARP MedicareComplete SecureHorizons Essential
- AARP MedicareComplete SecureHorizons Premier
- AARP MedicareComplete SecureHorizons Value
- AARP MedicareRx Enhanced (PDP)
- AARP MedicareRx Preferred (PDP)
- AARP MedicareRx Preferred (PDP)
- Compass Rose Health Plan FEHP FFS (PPO)
- Copay Select
- Definity Choice Plus
- Definity PPO
- Dual Complete LP
- Dual Complete RP
- Evercare Plan DH (HMO SNP)
- Evercare Plan RDP (RPPOSNP)
- Harvard Pilgrim Choice
- Harvard Pilgrim Choice Plus
- Harvard Pilgrim Options
- Healthy NY
- Heritage Choice
- Heritage Choice Standard
- Heritage Plus - Arkansas
- Heritage Plus - Georgia
- Heritage Plus - North Carolina
- Heritage Plus - South Carolina
- Heritage Plus/Heritage EPO
- Heritage Premier
- Heritage Select
- M.D. IPA
- M.D. IPA Preferred
- Medica Choice
- Medicare Advantage HMO
- Medicare Advantage PFFS
- Medicare Advantage POS
- Medicare Advantage PPO
- MedicareComplete Choice Essential
- MedicareComplete Choice Plan 2
- MedicareComplete Essential
- MedicareComplete Plan 1
- MedicareComplete Plus
- Neighborhood Health Partnership (NHP) - Commercial
- Neighborhood Health Partnership (NHP) - Mercy Select
- Nursing Home Plan
- Optimum Choice
- Optimum Choice Preferred
- Pacificare SignatureElite Plus
- River Valley Choice Plus
- Secure Horizons Medicare
- Sharp SecureHorizons Plan by UnitedHealthcare
- Sierra Health and Life
- SignatureValue Advantage
- SignatureValue HealthCare Partners Network
- Suite Spot
- The Empire Plan
- United Behavioral Health
- United HealthOne
- United Healthcare Navigate
- United Healthcare Navigate Plus
- United Healthcare Navigate/Navigate Balanced
- UnitedHealthcare Basics
- UnitedHealthcare Catalyst
- UnitedHealthcare Choice
- UnitedHealthcare Choice HMO/Choice Plus HMO
- UnitedHealthcare Choice Plus
- UnitedHealthcare Community Plan for Families
- UnitedHealthcare Community Plan for Kids
- UnitedHealthcare Core
- UnitedHealthcare Dental Options PPO
- UnitedHealthcare Dual Advantage
- UnitedHealthcare Dual Complete (HMO SNP)
- UnitedHealthcare EDGE
- UnitedHealthcare Heritage
- UnitedHealthcare Mutli-Choice
- UnitedHealthcare Options PPO
- UnitedHealthcare Pledge
- UnitedHealthcare Select EPO
- UnitedHealthcare Select HMO
- UnitedHealthcare Select Plus HMO
- UnitedHealthcare Select Plus POS
- UnitedHealthcare iPlan Choice Plus
- UnitedHealthcare iPlan PPO
Dr. David Barad M.D.'s Practice location
Request An Appointment With Dr. David Barad M.D. | OB-GYN (Obstetrician-Gynecologist) | Reproductive Endocrinology
Please note that this request is not considered final until you receive email notification confirming the details.
In the event the doctor is not yet registered with FindaTopDoc, we will contact the office on your behalf in an effort to secure your appointment.
Dr. David Barad M.D.'s reviewsWrite Review
Patient Experience with Dr. Barad
- Treatment Options for Cervical Cancer
Cervical cancer is one of the most common types of cancer in women. However, unlike the other forms of cancer, cervical cancer can be cured if it is discovered early on. That’s why cervical screening tests are necessary.Cervical cancer usually has no apparent symptoms in the primary stages. The...
- Low-Dose Aspirin May Cut Ovarian Cancer Risk
Aspirin, a nonsteroidal anti-inflammatory drug, can help with many health problems. It can reduce fever, ease pain, and even prevent a heart attack or stroke. For some time now researchers have looked into the connection between aspirin and cancer prevention. ...
- What Every Woman Should Know About Ovarian Cysts
Many women get an ovarian cyst of some type at some point in their life. Most are benign and do not cause any long-term harm. Having ovarian cysts certainly does not mean ovarian cancer. In fact, according to the provider reference Up To Date, most ovarian cysts do not need to be removed through...
- What You Need to Know About Osteoporosis
Osteoporosis is a medical condition that if diagnosed on time could be preventable and successfully treatable. In literal terms, osteoporosis means ‘bones with holes’. It is often called “the silent thief” because bone loss occurs without symptoms.But what is osteoporosis? According to WHO...
- Holistic Treatments for Fibroids
If your fibroids aren’t accompanied by any symptoms, you shouldn’t mind about treatment. Instead, your GP will suggest watchful waiting. This implies that you’ll have frequent pelvic examinations to establish fibroid tumors and symptoms. Ask your doctor the regularity of the check up so that...
- What is Weight Loss Surgery?
Surgical options that help to limit the intake of food or absorption of nutrients resulting in the loss of weight are known as weight loss surgeries. Also referred to as bariatric surgery, this option is often recommended for those who have severe obesity. This option has been in practice for many...
- Dr. Peter Guirguis M.D.464 77th Street Brooklyn New York 11209
- Anat Zelmanovich509 East 77th Street New York New York 10075
- Dr. Juanita Mestre-Dudley M.D.200 Garden City Plaza Garden City New York 11530
- Dr. Karen L. Patrusky MD401A South Van Brunt Street Englewood New Jersey 07631
- Dr. Bradley Trivax MD200 Old Country Rd Mineola NY 11501
- Dr. Linda Sung M.D.200 Old Country Rd Mineola NY 11501